Solesence Inc: Segment Analysis

Solesence Inc (Solesence) is primarily engaged in the development and manufacture of skin health and sun care products. The company focuses on creating consumer products, personal care ingredients, and advanced materials. It operates under current Good Manufacturing Standards (cGMP) as enforced by the U.S. Food and Drug Administration (FDA) and serves industries such as consumer products, personal care, and advanced materials.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

The company’s R&D also focuses on the Solesence beauty science product and personal care ingredient applications development. The company's R&D efforts are focused on application development for their products, creating or obtaining additional core materials technologies, and improving their core technologies to enhance manufacturing operations and reduce costs. The R&D units of Solesence include R&D, cosmetic formulating, process engineering, and advanced engineering groups. These units are responsible for application development for their products, creating or obtaining additional core materials technologies, and improving their core technologies to enhance manufacturing operations and reduce costs. In FY2024, Solesence's R&D expenditure stood at US$3.8 million, which as a percentage of total revenue stood at 7.3%. As of December 2024, the company owns 10 US patents and five pending US patent applications. The company also owns 108 foreign patents and patent applications, consisting of 68 issued or allowed foreign patents and 40 pending foreign patent applications.